John Hoekman - Dec 22, 2021 Form 4 Insider Report for IMPEL NEUROPHARMA INC (IMPL)

Role
Chief Scientific Officer
Signature
/s/ John Leaman, M.D. as attorney-in-fact
Stock symbol
IMPL
Transactions as of
Dec 22, 2021
Transactions value $
$32,800
Form type
4
Date filed
12/23/2021, 03:50 PM
Previous filing
Jul 26, 2021
Next filing
Jan 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMPL Common Stock Options Exercise $32.8K +20K +18.48% $1.64 128K Dec 22, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMPL Stock Option (right to buy) Options Exercise $0 +20K $0.00* 0 Dec 22, 2021 Common Stock 20K $1.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is 100% vested and exercisable.